Surgeon:

No

Mohammed Morshed Tamim, MD, FAAP, is Neonatology Attending, Neonatology Department, Cleveland Clinic Foundation.

Dr. Tamim is board certified in general pediatrics and neonatal-perinatal medicine. He is Neonatal Resuscitation Program Instructor (NRP) and Pediatric Advanced Life Support (PALS) Provider. He also is a certified member of Life Flight Team for Neonatal Transport.
He earned his medical degree from Damascus University Medical School in Damascus, Syria. His post-graduate training includes Pediatric Residency and Neonatal-Perinatal Fellowship at MetroHealth Medical Center, which is affiliated with Case Western Reserve University (Case Medical School) in Cleveland.
 Dr. Tamim is a Diplomate of the American Board of Pediatrics and a member of several professional associations. 
Dr. Tamim has published multiple research articles in peer-reviewed journals and has contributed abstracts and presentations at a number of professional association meetings.
His specialty interests include Neonatal Mechanical Ventilation, Neonatal Resuscitation and Neonatal Infectious Diseases.

Professional Appointments: 

2011- Present:    Neonatology staff, Neonatology Department,  Cleveland Clinic Foundation, Cleveland, Ohio.
 
2007- 2011:       Consultant Neonatologist, Pediatric Department, NICU, Tawam Hospital in affiliation with

                          Johns Hopkins Medicine. Al Ain, United Arab Emirates.
                          Clinical Assistant Professor, Faculty of Health and Medical Seince,  
                          United Arab Emirates University, Alain, UAE.
                          Neonatology Consultant and lecturer, Syria 
2006                  Chief of Service, Neonatal Intensive Care Unit. The Governor Juan F. Luis Hospital,
                          Christiansted, St. Croix, Virgin Islands, U.S.A.

2002 - 2005       Pediatric Residency, Pediatric Department, MetroHealth  Medical Center,
                          Case Western Reserve University, Cleveland, OH         
1999- 2002       Neonatology Fellowship. Neonatal-Perinatal Medicine Fellow,  

                          Neonatology Division, Pediatric Department, MetroHealth

                          Medical Center, Case Western Reserve University, Cleveland, OH                                      

1996-1999        Senior House Officer, Level III Neonatal Intensive Care Unit,

                          Dubai Hospital, Dubai, United Arab Emirates.

1991-1996        Senior House Officer, General Pediatrics and Neonatology,

                          Dubai Hospital, Department of Health and Medical Services

                          Dubai, United Arab Emirates.

Residency - MetroHealth Medical Center

Pediatrics
Cleveland, OH USA
2005

Fellowship - MetroHealth Medical Center

Neonatal-Perinatal Medicine
Cleveland, OH USA
2002

Medical School - Damascus University-Faculty of Medicine

Damascus Syria
1986

• Pediatrics
• Pediatrics- Neonatal-Perinatal Medicine

• Excellence of Teaching Award in 2009-2010 academic year, Faculty of Medicine and Health Science, UAE University.
• Physician Recognition Award, American Medical Association (2002–2005).
• Medical School Scholarship from United Arab Emirates Embassy, Damascus, Syria (1981- 1986).
• The first in the elementary and primary schools, and among the first ten in the high school.

Summer 2002                Successfully completed the course of Introduction to Clinical Research,
 Case Western Reserve University, Cleveland. OH, USA.

9/1/2000-6/30/2001      Successfully completed the two semester course on Research Design and
                                     Biostatistics. MetroHealth Medical Center, Case Western Reserve University,
                                     Cleveland, OH. 

4/16/1989-4/15/1991:   Pediatric Residency Training (First Pediatric Residency):                                          

                                     Alwasl Hospital, Department of Health and Medical Services, Dubai, UAE.

Publications

·        M. M.Tamim, Hassan Alesseh and Hany Aziz: (Analysis of the Efficacy of Urine Culture as Part of Sepsis Evaluation in the Premature Infant), the Pediatric Infectious Disease Journal, Vol.22, No. 9, Sept. 2003.

·        Abdulla Gori, M.Tamim and John Moore: Fetomaternal Hemorrhage, Pediatric in Review Vol. 22 No.4 April 2001.

·        Eman Al Reyami, Khawla Al Zoabi, Aiman Rahmani, Mohammed Tamim, Fares Chedid:  (Is isolation of outborn infants required at admission to the neonatal intensive care unit),  AJIC: American Journal of Infection Control, Feb. 2009.

·        G. N. Bekdache, M. A. Hamdan, M. A. Begam, F. Chedid, M. M.Tamim, H. Mirghani: (Prenatal Diagnosis of Extrahepatic Umbilicoportosystemic Shunt: Impact on Postnatal Management), Journal of Obstetrics and Gynaecology; the Journal of the Institute of Obstetrics and Gynaecology Aug. 2011; 31(6): 542-3

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/5/2013, Dr. Tamim has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.